SV

Sunil Vastupal Shah

Active Director Designated Partner DIN 09143686
DIN 09143686 First appointment Apr 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Sunil Vastupal Shah

Data last updated:

Sunil Vastupal Shah is a Designated Partner at Gadhinglaj Pharma Llp (since 2021). The company operates in Healthcare.

DIN 09143686
Primary Designation Designated Partner
Industry Healthcare
First Appointment 21 Apr 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 Apr 20212021Active

Directorship timeline

Open interactive timeline →
Gadhinglaj Pharma Llp
Premium access

Shareholding and investment profile for Sunil Vastupal Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunil Vastupal Shah

Sunil Vastupal Shah currently holds 1 directorship: Gadhinglaj Pharma Llp (Designated Partner, since 21 Apr 2021).

Sunil Vastupal Shah was first appointed on 21 Apr 2021 as Designated Partner at Gadhinglaj Pharma Llp.

The current boards of Sunil Vastupal Shah's companies include Abhishek Gadvi Mallikarjun (Gadhinglaj Pharma Llp), Amarnath Mallappa Banage (Gadhinglaj Pharma Llp), Kiran Ananda Sawant (Gadhinglaj Pharma Llp), Mahendra Chunilal Shah (Gadhinglaj Pharma Llp), Mallinath Kadappa Hanji (Gadhinglaj Pharma Llp), Nagesh Ishwarappa Mungurawadi (Gadhinglaj Pharma Llp), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available